Know Cancer

or
forgot password

    • cancer clinical trials in boston, MA

    • Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
    Floating Hospital for Children
    Boston, Massachusetts 02111
    Melanoma (Skin), Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Boston Medical Center
    Brigham and Women's Hospital
    Breast Cancer
    Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
    St. Elizabeth's Medical Center
    Boston, Massachusetts 02135-2997
    Pancreatic Cancer
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Boston Floating Hospital Infants and Children
    Dana-Farber Cancer Institute
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    VX-710, Doxorubicin, and Vincristine in Treating Patients With Recurrent Small Cell Lung Cancer
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Lung Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Cancer Research Center at Boston Medical Center
    Brigham and Women's Hospital
    Breast Cancer
    Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
    Dana-Farber/Brigham and Women's Cancer Center
    Boston, Massachusetts 02115
    Leukemia
    Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Prostate Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    Massachusetts General Hospital Cancer Center
    Boston, Massachusetts 02114
    Bladder Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Boston Floating Hospital Infants and Children
    Dana-Farber Cancer Institute
    Brain and Central Nervous System Tumors
    Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Veno-Occlusive Disease
    Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Cardiac Toxicity, Leukemia
    Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Head and Neck Cancer
    Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Head and Neck Cancer
    Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Leukemia
    STI571 in Treating Patients With Recurrent Leukemia
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Floating Hospital for Children
    Leukemia
    Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Prostate Cancer
    Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Floating Hospital for Children
    Brain and Central Nervous System Tumors
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Leukemia
    Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Fanconi's Anemia
    Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Brigham and Women's Hospital
    Prostate Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Boston University Cancer Research Center
    Boston, Massachusetts 02118
    Lung Cancer
    Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Melanoma (Skin)
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Head and Neck Cancer
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Medical Center of Boston
    Boston, Massachusetts 02120
    Colorectal Cancer
    BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Lung Cancer
    Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Leukemia
    Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Sarcoma
    Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain
    Brigham and Women's Hospital
    Boston, Massachusetts 02115
    Constipation, Impaction, and Bowel Obstruction, Unspecified Adult Solid Tumor, Protocol Specific